Merav Bassan
Corporate Officer/Principal bei BIOMX INC.
Vermögen: - $ am 31.03.2024
Profil
Merav Bassan is currently the Chief Development Officer at BiomX Ltd.
and BiomX, Inc. She is also a member of 8400 Health Network.
Previously, she worked at Teva Pharmaceutical Industries Ltd.
as Vice President from 2009 to 2019.
She received her undergraduate and graduate degrees from Tel-Aviv University and her doctorate from Sackler School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOMX INC.
-.--% | 11.12.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Merav Bassan
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOMX INC. | Corporate Officer/Principal | 28.10.2019 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Corporate Officer/Principal | 01.10.2019 |
| 8400 Health Network | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Merav Bassan
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Merav Bassan
| Tel-Aviv University | Graduate Degree |
| Sackler School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BIOMX INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
| 8400 Health Network |
